ArticleDiabetes technology & therapeutics2019

Reversal of Ketosis in Type 1 Diabetes Is Not Adversely Affected by SGLT2 Inhibitor Therapy.

Stephan Siebel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.